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Subcutaneous cardioverter-defibrillator (S-ICD) is a device that has been implanted in Europe since 2009. Indications 
for a S-ICD in the prevention of sudden cardiac death are the same as for a conventional transvenous ICD, with the 
exception that the S-ICD is not capable of terminating ventricular arrhythmias with anti-tachycardia pacing, but it can 
solely use 80-joule electric shocks. The S-ICD system consists of a can, placed subcutaneously (or under the muscles of 
the thoracic wall) on the level of the fifth left intercostal space in midaxillary line, and a lead also placed subcutaneously, 
along the left border of the sternum. Until now, such defibrillators have not been implanted in Poland. A man aged 
40 years was admitted to our clinic in January 2014 because of pain and livedo of the S-ICD pocket (Cameron Health 
model 1010 SQ-RX). The device had been implanted in the United States in December 2013, because of prior primary 
ventricular fibrillation (VF). Physical examination showed substantial skin thinning over the S-ICD can and its local livedo 
(Fig. 1). Threatening pocket erosion was diagnosed. Laboratory tests did not show signs of systemic bacterial infection. 
Because of the clinical picture and the history of signs and symptoms directly following the implantation procedure, and 
a substantial risk of pocket infection, we initially decided to remove the system and replace it with a transvenous ICD. 
Because of the patient’s preference, bearing in mind a low procedural risk of the possible future system removal in case 
of bacterial infection, we then decided to perform the pocket plasty. On 21 February 2014, under general anaesthesia, 
the S-ICD pocket was opened with a left subscapular incision. No macroscopic signs of infection were observed. The 
axillary border of the muscle latissimus dorsi was dissected free, and the posterior edge of the S-ICD can was displaced 
underneath it. Subsequently, from the incision anterior to the can, the border of the serratus muscle was dissected free 
and sutured to the previously freed margin of the muscle latissimus dorsi over the can, which resulted in complete cov-
erage with a muscle layer. The lead was neither dissected nor displaced. ICD test was conducted immediately after the 
procedure. VF was induced twice. The first VF episode was not terminated with a test shock of 65 J. After polarity change, 
a second attempt resulted in successful defibrillation (65 J). The patient was discharged after three days. Sutures were 
removed after ten days. Two months later, we confirmed the correct healing of the wounds (Fig. 2). The case described 
above proves how important is the correct placement of the S-ICD can. Too shallow location (directly underneath the 
skin surface) may lead to a threatening erosion of the device pocket. 
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Figure 1. S-ICD pocket directly before the plasty 
procedure
Figure 2. S-ICD pocket two months 
after the plasty procedure 
